MedTrace Logo

Pilot Study About Tamoxifen Therapy for Breast Cancer Patients

NCT02094495 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2014-06-26

No results posted yet for this study

Summary

The aim of this study are to to evaluate the knowledge and understanding on tamoxifen theraphy for breast cancer patients and examine the decision conflict scale and satisfaction with decision scale while making decision to take tamoxifen.

Conditions

Sponsors & Collaborators

  • National Cancer Center, Korea

    lead OTHER_GOV

Principal Investigators

  • Eun Sook Lee, MD, PhD · National Cancer Center, Korea

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02094495 on ClinicalTrials.gov